RØYRVIK ET AL.133. Guanti G, Resta N, Simone C, Cariola F, Demma I, Fiorente P, Gentile M. Involvementof PTEN mutations <strong>in</strong> the <strong>genetic</strong> pathways of colorectal cancerogenesis.Hum Mol Genet. 2000;9:283–7.134. Bussaglia E, del RE, Matias-Guiu X, Prat J. PTEN mutations <strong>in</strong> endometrialcarc<strong>in</strong>omas: a molecular <strong>and</strong> cl<strong>in</strong>icopathologic analysis of 38 cases. HumPathol. 2000;31:312–7.135. Cohn DE, Basil JB, Venegoni AR, Mutch DG, Rader JS, Herzog TJ, GersellDJ, Goodfellow PJ. Absence of PTEN repeat tract mutation <strong>in</strong> endometrialcancers with microsatellite <strong>in</strong>stability. Gynecol Oncol. 2000;79:101–6.136. Dicuonzo G, Angeletti S, Garcia-Foncillas J, Brugarolas A, Okrouzh<strong>no</strong>v Y,Sant<strong>in</strong>i D, Ton<strong>in</strong>i G, Lor<strong>in</strong>o G, De CM, Baldi A. Colorectal carc<strong>in</strong>omas <strong>and</strong>PTEN/MMAC1 gene mutations. Cl<strong>in</strong> Cancer Res. 2001;7:4049–53.137. Zhou XP, Loukola A, Salovaara R, Nystrom-Lahti M, Peltomaki P, de la CA,Aaltonen LA, Eng C. PTEN mutational spectra, expression levels, <strong>and</strong> subcellularlocalization <strong>in</strong> microsatellite stable <strong>and</strong> unstable colorectal cancers. Am JPathol. 2002;161:439–47.138. Vilkki S, Lau<strong>no</strong>nen V, Karhu A, Sistonen P, Vastrik I, Aaltonen LA. Screen<strong>in</strong>gfor microsatellite <strong>in</strong>stability target genes <strong>in</strong> colorectal cancers. J Med Genet.2002;39:785–9.139. Iglesias D, Fern<strong>and</strong>ez-Peralta AM, Nejda N, Daimiel L, Azcoita MM, Oliart S,Gonzalez-Aguilera JJ. RIS1, a gene with tr<strong>in</strong>ucleotide repeats, is a target <strong>in</strong> themutator pathway of colorectal carc<strong>in</strong>ogenesis. Cancer Genet Cytogenet.2006;167:138–44.140. Piao Z, Fang W, Malkhosyan S, Kim H, Horii A, Perucho M, Huang S. Frequentframeshift mutations of RIZ <strong>in</strong> sporadic gastro<strong>in</strong>test<strong>in</strong>al <strong>and</strong> endometrialcarc<strong>in</strong>omas with microsatellite <strong>in</strong>stability. Cancer Res. 2000;60:4701–4.141. Sakurada K, Furukawa T, Kato Y, Kayama T, Huang S, Horii A. RIZ, the ret<strong>in</strong>oblastomaprote<strong>in</strong> <strong>in</strong>teract<strong>in</strong>g z<strong>in</strong>c f<strong>in</strong>ger gene, is mutated <strong>in</strong> <strong>genetic</strong>ally unstablecancers of the pancreas, stomach, <strong>and</strong> colorectum. Genes ChromosomesCancer. 2001;30:207–11.142. Pan KF, Lu YY, Liu WG, Zhang L, You WC. Detection of frameshift mutationsof RIZ <strong>in</strong> gastric cancers with microsatellite <strong>in</strong>stability. World J Gastroenterol.2004;10:2719–22.143. Hie<strong>no</strong>nen T, Sammalkorpi H, Enholm S, Alhopuro P, Barber TD, Lehtonen R,Nupponen NN, Lehtonen H, Salovaara R, Meckl<strong>in</strong> JP, Jarv<strong>in</strong>en H, Koist<strong>in</strong>en R,Arango D, Lau<strong>no</strong>nen V, Vogelste<strong>in</strong> B, Karhu A, Aaltonen LA. Mutations <strong>in</strong>two short <strong>no</strong>ncod<strong>in</strong>g mo<strong>no</strong>nucleotide repeats <strong>in</strong> most microsatellite-unstablecolorectal cancers. Cancer Res. 2005;65:4607–13.254
TARGET GENES OF MSI COLORECTAL CANCER144. Yamamoto H, Perez-Piteira J, Yoshida T, Terada M, Itoh F, Imai K, PeruchoM. Gastric cancers of the microsatellite mutator phe<strong>no</strong>type display characteristic<strong>genetic</strong> <strong>and</strong> cl<strong>in</strong>ical features. Gastroenterology. 1999;116:1348–57.145. Kloor M, Becker C, Benner A, Woerner SM, Gebert J, Ferrone S, von KnebelDM. Immu<strong>no</strong>selective pressure <strong>and</strong> human leukocyte antigen class I antigenmach<strong>in</strong>ery defects <strong>in</strong> microsatellite unstable colorectal cancers. Cancer Res.2005;65:6418–24.146. Nakagawa H, Koyama K, Nakamori S, Kameyama M, Imaoka S, MondenM, Nakamura Y. Frameshift mutation of the STK11 gene <strong>in</strong> a sporadic gastro<strong>in</strong>test<strong>in</strong>alcancer with microsatellite <strong>in</strong>stability. Jpn J Cancer Res. 1999;90:633–7.147. Shimizu Y, Ikeda S, Fujimori M, Kodama S, Nakahara M, Okajima M,Asahara T. Frequent <strong>alterations</strong> <strong>in</strong> the Wnt signal<strong>in</strong>g pathway <strong>in</strong> colorectal cancerwith microsatellite <strong>in</strong>stability. Genes Chromosomes Cancer. 2002;33:73–81.148. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, K<strong>in</strong>zlerKW, Lutterbaugh J, Park K. A transform<strong>in</strong>g growth factor beta receptortype II gene mutation common <strong>in</strong> colon <strong>and</strong> gastric but rare <strong>in</strong> endometrial cancerswith microsatellite <strong>in</strong>stability. Cancer Res. 1995;55:5545–7.149. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, K<strong>in</strong>zler KW, Vogelste<strong>in</strong>B. Microsatellite <strong>in</strong>stability <strong>and</strong> mutations of the transform<strong>in</strong>g growthfactor beta type II receptor gene <strong>in</strong> colorectal cancer. Cancer Res.1995;55:5548–50.150. Renault B, Calistri D, Buonsanti G, Nanni O, Amadori D, Ranzani GN. Microsatellite<strong>in</strong>stability <strong>and</strong> mutations of p53 <strong>and</strong> TGF-beta RII genes <strong>in</strong> gastriccancer. Hum Genet. 1996;98:601–7.151. Olschwang S, Hamel<strong>in</strong> R, Laurent-Puig P, Thuille B, De RY, Li YJ, Muzeau F,Girodet J, Salmon RJ, Thomas G. Alternative <strong>genetic</strong> pathways <strong>in</strong> colorectalcarc<strong>in</strong>ogenesis. Proc Natl Acad Sci U S A. 1997;94:12122–7.152. Iacopetta BJ, Welch J, Soong R, House AK, Zhou XP, Hamel<strong>in</strong> R. Mutation ofthe transform<strong>in</strong>g growth factor-beta type II receptor gene <strong>in</strong> right-sided colorectalcancer: relationship to cl<strong>in</strong>icopathological features <strong>and</strong> <strong>genetic</strong> <strong>alterations</strong>. JPathol. 1998;184:390–5.153. Ohwada M, Suzuki M, Saga Y, Suzuki T, Ikeda M, Yamada M, Sato I. Mutationalanalysis of transform<strong>in</strong>g growth factor beta receptor type II <strong>and</strong> DNAmismatch repair genes <strong>in</strong> sporadic endometrial carc<strong>in</strong>omas with microsatellite<strong>in</strong>stability. Oncol Rep. 2000;7:789–92.154. Watanabe T, Wu TT, Catala<strong>no</strong> PJ, Ueki T, Satria<strong>no</strong> R, Haller DG, Benson AB,III, Hamilton SR. Molecular predictors of survival after adjuvant chemotherapyfor colon cancer. N Engl J Med. 2001;19;344:1196–206.255
- Page 1 and 2:
Novel genetic and epigenetic altera
- Page 3 and 4:
TABLE OF CONTENTSACKNOWLEDGEMENTS .
- Page 5 and 6:
ACKNOWLEDGEMENTSThe present work ha
- Page 7 and 8:
Prefacetechnology[3]. This new tech
- Page 10 and 11:
SummaryThe subgroup of carcinomas w
- Page 12 and 13:
Introduction“Epigenetic inheritan
- Page 14 and 15:
Introductionamino acid change it is
- Page 16 and 17:
Introductionmethylation during embr
- Page 18 and 19:
IntroductionDNA is most of the time
- Page 20 and 21:
IntroductionFigure 5. DNA methylati
- Page 22 and 23:
IntroductionFigure 6. Incidence rat
- Page 24 and 25:
IntroductionFigure 8. Tumor staging
- Page 26 and 27:
Introductioninasmuch as 80% of colo
- Page 28 and 29:
IntroductionInstabilities involved
- Page 30 and 31:
Introductionthere seems to be a fid
- Page 32 and 33:
Introductionsevere alterations are
- Page 34 and 35:
Introductionpopulation-wide screeni
- Page 36 and 37:
IntroductionFigure 12. Present and
- Page 38 and 39:
RESULTS IN BRIEFPaper Ia. “DNA hy
- Page 40 and 41:
Results in Briefinstability, and se
- Page 42 and 43:
Results in BriefUnivariate survival
- Page 44 and 45:
Discussionseveral factors, and full
- Page 46 and 47:
Discussionlow threshold, we increas
- Page 48 and 49:
DiscussionIt may seem like unnecess
- Page 50 and 51:
Discussionthan 96% DHPLC do not sta
- Page 52 and 53:
DiscussionFigure 13. Mutation detec
- Page 54 and 55:
DiscussionClinical impact of molecu
- Page 56 and 57:
Discussionmarkers with a very high
- Page 58 and 59:
Discussionchromosomes in metaphase[
- Page 60 and 61:
DiscussionThese examples underline
- Page 62 and 63:
Discussiongenes. One is based on mu
- Page 64 and 65:
CONCLUSIONSWe have identified novel
- Page 66 and 67:
Future PerspectivesMolecular risk a
- Page 68 and 69:
REFERENCES1. Breasted J (1930) The
- Page 70 and 71:
References29. Deng G, Chen A, Pong
- Page 72 and 73:
References57. Al-Sukhni W, Aronson
- Page 74 and 75:
References84. Kunkel TA (1993) Nucl
- Page 76 and 77:
ReferencesLeggett B, Levine J, Kim
- Page 78 and 79:
References133. Lind GE, Thorstensen
- Page 80 and 81:
References156. Meling GI, Lothe RA,
- Page 82 and 83:
ReferencesT, Song X, Day RH, Sledzi
- Page 84 and 85:
References196. Honda S, Haruta M, S
- Page 86 and 87:
ORIGINAL ARTICLESAPPENDIXAppendix I
- Page 89 and 90:
GASTROENTEROLOGY 2007;132:1631-1639
- Page 91:
Paper IbGuro E Lind, Terje Ahlquist
- Page 94 and 95:
Journal of Translational Medicine 2
- Page 96 and 97:
Journal of Translational Medicine 2
- Page 98 and 99:
Journal of Translational Medicine 2
- Page 100 and 101:
Journal of Translational Medicine 2
- Page 102 and 103:
Journal of Translational Medicine 2
- Page 105:
Paper IITerje Ahlquist, Guro E Lind
- Page 108 and 109:
BackgroundMost cases of colorectal
- Page 110 and 111:
ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
- Page 112 and 113:
pseudogene, leading to a high rate
- Page 114 and 115:
strands. Proc Natl Acad Sci U S A 1
- Page 116 and 117:
concomitant absence of transcript a
- Page 119 and 120:
Volume 10 Number 7 July 2008 pp. 68
- Page 121 and 122:
682 RAS Signaling in Colorectal Car
- Page 123 and 124:
684 RAS Signaling in Colorectal Car
- Page 125 and 126:
686 RAS Signaling in Colorectal Car
- Page 127:
Table W2. Detailed Somatic Events o
- Page 131 and 132:
Identification of RCC2 as a prognos
- Page 133 and 134:
INTRODUCTIONMicrosatellite instabil
- Page 135 and 136:
unselected series of primary tumors
- Page 137 and 138: specificity, i.e. that they only am
- Page 139 and 140: On the assumption that DNA repair a
- Page 141 and 142: In order to ensure that gene mutati
- Page 143 and 144: Figure 2. Mutation frequency differ
- Page 145 and 146: and TAF1B (0.50), ACVR2A and ASTE1
- Page 147 and 148: Multivariate analysesA multivariate
- Page 149 and 150: When comparing our findings of muta
- Page 151 and 152: The test series included a low numb
- Page 153 and 154: entering M-phase remains to be seen
- Page 155 and 156: 12. Duval A, Reperant M, Hamelin R
- Page 157 and 158: 34. Martineau-Thuillier S, Andreass
- Page 159: AppendicesAppendix I:List of abbrev
- Page 163 and 164: Critical Reviews TM in Oncogenesis,
- Page 165 and 166: TARGET GENES OF MSI COLORECTAL CANC
- Page 167 and 168: TARGET GENES OF MSI COLORECTAL CANC
- Page 169 and 170: TARGET GENES OF MSI COLORECTAL CANC
- Page 171 and 172: TARGET GENES OF MSI COLORECTAL CANC
- Page 173 and 174: TARGET GENES OF MSI COLORECTAL CANC
- Page 175 and 176: TARGET GENES OF MSI COLORECTAL CANC
- Page 177 and 178: TARGET GENES OF MSI COLORECTAL CANC
- Page 179 and 180: TARGET GENES OF MSI COLORECTAL CANC
- Page 181 and 182: TARGET GENES OF MSI COLORECTAL CANC
- Page 183 and 184: TARGET GENES OF MSI COLORECTAL CANC
- Page 185 and 186: TARGET GENES OF MSI COLORECTAL CANC
- Page 187: TARGET GENES OF MSI COLORECTAL CANC
- Page 191: TARGET GENES OF MSI COLORECTAL CANC